Correspondence 0001477932-24-003783 from VOLITIONRX LTD (VNRX)
VOLITIONRX LTD
Date: June 21, 2024 · CIK: 0000093314 · Accession: 0001477932-24-003783
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-280217
Letter
vnrx_corresp.htmVOLITIONRX LIMITED
1489 West Warm Springs Road, Suite 110
Henderson, Nevada 89014
June 21, 2024
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Chris Edwards
Re:
VolitionRx Limited Acceleration Request
Registration Statement on Form S-3
Filed June 14, 2024
File No. 333-280217
Requested Date:
June 25, 2024
Requested Time:
5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com. We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective.
Sincerely,
VOLITIONRX LIMITED
Show Raw Text
CORRESP
1
filename1.htm
vnrx_corresp.htmVOLITIONRX LIMITED
1489 West Warm Springs Road, Suite 110
Henderson, Nevada 89014
June 21, 2024
SUBMITTED VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Mr. Chris Edwards
Re:
VolitionRx Limited Acceleration Request
Registration Statement on Form S-3
Filed June 14, 2024
File No. 333-280217
Requested Date:
June 25, 2024
Requested Time:
5:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), VolitionRx Limited, a Delaware corporation (the “Company”), hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to declare the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable.
Should the Commission have any questions regarding this acceleration request, please do not hesitate to contact Marc G. Alcser, an attorney with the Company’s outside legal counsel, Stradling Yocca Carlson & Rauth LLP, via telephone at (949) 725-4136 or via email at malcser@stradlinglaw.com. We respectfully request that you contact Mr. Alcser via telephone as soon as the above referenced Registration Statement has been declared effective.
Sincerely,
VOLITIONRX LIMITED
/s/ Cameron Reynolds
Cameron Reynolds
President and Chief Executive Officer
cc:
VolitionRx Limited
Terig Hughes, Chief Financial Officer
Stradling Yocca Carlson & Rauth LLP
Marc G. Alcser, Esq.